Household Products

Colgate

Coca-Cola

Financial Analysis

COLA

COLAR

COLAU

Coca Cola

Columbus Acquisition

PepsiCo

Procter & Gamble

COLUMBUS ACQUISITION CORP COM USD0.0001 30/09/2025 (SUB/RIGHTS)

Columbus Acquisition - Unit

Zero-sugar lines are surging and AI-driven cost cuts are taking hold. Cola is winning big.

Colgate-Palmolive EVP Malcolm Gregory Sells 2,300 Shares

World Investment Advisors Increases Colgate-Palmolive Stake by 102.4%

Blackhawk Capital Partners LLC Increases Procter & Gamble Shares in Q4

Colgate-Palmolive's Chief People Officer Sold Company Stocks

JPMorgan Raises Colgate Stock Target Price to $96

Goldman Sachs Raises Colgate-Palmolive's Target Price to $100

Colgate released FY2026 Q1 earnings on May 1 Pre-Market EST, actual revenue USD 5.324 B (forecast USD 5.215 B), actual EPS USD 0.8 (forecast USD 0.9451)

Colgate Palmolive Executives Reveal Earnings Forecast Assuming Oil Prices Remain at $110 Per Barrel

Denhac Pension and Life Insurance Reduced Holdings in Colgate

RBC Predicts Colgate-Palmolive's Q1 Earnings to Meet Expectations

Colgate to Release FY2026 Q1 Earnings on May 1, Pre-Market EST; Forecast Revenue USD 5.215 B, EPS USD 0.9451

Toothpaste Brands Play Word Games in Whitening Trademark Registrations

J.P. Morgan Maintains Hold Rating on Colgate-Palmolive (India) Ltd

Compagnie Lombard Odier SCmA Significantly Reduced Holdings in Colgate-Palmolive

TD Cowen Downgrades Colgate-Palmolive Ratings

Alps Bank Wealth Management Reduces Procter & Gamble Shares

Deutsche Bank Upgrades Colgate-Palmolive to Buy

Norden Group Significantly Reduces Procter & Gamble Shares

Colgate-Palmolive Reorganizes Reportable Segments

DoubleLine ETF Adviser LP Buys New Position in Colgate-Palmolive

NextNRG

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

InMed Pharmaceuticals

Amesite

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Meiwu Tech

CN Energy

MetaVia

Generation Income Properties

Co-Diagnostics

Colgate-Palmolive Company (CL.US) Q3 2025 Earnings Conference Call

Colgate-Palmolive Company (CL.US) Q2 2025 Earnings Conference Call

Colgate-Palmolive Company (CL.US) Q4 2024 Earnings Conference Call

FTXG

World Investment Advisors increased its stake in Colgate-Palmolive Company by 102.4% in Q4, owning 25,704 shares valued at $2.03 million. Other investors like Vanguard and Invesco also raised their stakes. Analysts have mixed sentiments, with Morgan Stanley raising the price target to $100, while Zacks Research lowered FY2028 EPS estimates. Colgate's stock is currently rated as a 'Moderate Buy' with a price target of $95.88.

Market Beat

SPDR FD Consumer Staples

Invesco Food & Beverage ETF

First Trust NASDAQ Food & Beverage

VG Consumer Stap

ISHRS S&Pp Glb Cons Staple

Nano Labs

Invesco

Diamond Hill Investment

Ameriprise Financial

Morgan Stanley

UBS Group AG

Jefferies Financial

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

World Investment Advisors Has $2.03 Million Stock Holdings in Colgate-Palmolive Company $CL

ORCL

DXCM

ORCX

Marc Lichtenfeld from the Oxford Club recommends selling three stocks this May: DexCom, Colgate-Palmolive, and Oracle. He argues that the market's strong performance does not justify holding onto these positions due to various risks. DexCom faces increased competition and operational scrutiny, Colgate-Palmolive shows stagnant growth with no catalysts, and Oracle's financial commitments raise concerns about its future cash flow. Lichtenfeld emphasizes the importance of trimming weak positions in a portfolio during this period.

Oracle

DexCom

Defiance Daily Target 2X Long ORCL ETF

S&P 500

Abbott Laboratories

Black Hills

OpenAI

ORACLE CORP DEPOSITARY SH REP 1/2000TH PFD SER D

Sell in May and Go Away—Starting With These 3 Stocks

Blackhawk Capital Partners LLC acquired 11,755 shares of Colgate-Palmolive Company (NYSE:CL) in Q4, valued at approximately $929,000, as per their recent SEC filing. Other investors, including ProShare Advisors and Citigroup, also increased their stakes in the company. Analysts have mixed ratings on Colgate-Palmolive, with a consensus rating of "Moderate Buy" and an average target price of $95.88. The stock is currently down 1.0%, trading at $86.68, with a recent quarterly EPS of $0.97, exceeding estimates. The company has declared a quarterly dividend increase to $0.53 per share.

Citigroup

Toronto Dominion Bank

Wells Fargo

JPMorgan Chase

Evercore

Goldman Sachs

CITIGROUP INC 6.250 NON CUM SER II PFD WI

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

GS Hldg R

Blackhawk Capital Partners LLC Buys Shares of 11,755 Colgate-Palmolive Company $CL

Colgate-Palmolive reported Q1 2026 sales of $5.32 billion, up from $4.91 billion, but net income fell to $646 million from $690 million. Despite margin pressures, the company reaffirmed its 2026 net sales growth outlook of 2% to 6%. The investment narrative emphasizes the need for management to defend margins against rising costs, while the risk of sustained profitability pressure remains. Analysts project a fair value of $96.68 for the stock, indicating a potential 10% upside from its current price, with varying estimates among analysts.

Simplywall

What Colgate-Palmolive (CL)'s Q1 Margin Squeeze And Reaffirmed 2026 Outlook Mean For Shareholders

Sequoia Financial Advisors LLC increased its stake in Colgate-Palmolive Company (NYSE:CL) by 63.1% in Q4, owning 54,339 shares valued at $4.29 million. Other institutional investors also acquired shares, with 80.41% of the stock held by hedge funds. Colgate-Palmolive reported a Q1 EPS of $0.97, exceeding estimates, and announced a quarterly dividend of $0.53 per share. Analysts have mixed ratings, with a consensus of "Moderate Buy" and an average target price of $95.88.

Bank of America

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Sequoia Financial Advisors LLC Boosts Holdings in Colgate-Palmolive Company $CL

COST

The article discusses two consumer staples stocks, Procter & Gamble and Colgate-Palmolive, highlighting their deep integration into daily routines. Procter & Gamble's products are habitual choices for consumers, creating a psychological barrier to switching brands. The company is expanding into emerging markets, leveraging established brand loyalty. Colgate-Palmolive's toothpaste is a dominant choice globally, built on trust and professional endorsements rather than advertising. Both companies are positioned for long-term growth, making them solid investments for decades.

nasdaq

Target

Costco Wholesale

Kroger

NVIDIA

Intel

NVIDIA Corporation

The 2 Best Consumer Staples Stocks to Buy and Hold for Decades

Is Wall Street Bullish or Bearish on Colgate-Palmolive Stock?

Barchart Option

Is Wall Street Bullish or Bearish on Colgate-Palmolive Stock?

Quick Read JPMorgan raised its Colgate-Palmolive (CL) stock price target to $96 from $95, citing emerging markets exposure and a strong Q1 2026 beat that positions it to outperform staples peers. Colgate-Palmolive’s defensive appeal and 60-year dividend track record anchor its portfol...

JPMorgan lifts Colgate price target to $96: Why emerging markets are powering the defensive trade

RBC Capital analyst Nik Modi has reaffirmed a Buy rating for Colgate-Palmolive (CL) with a price target of $102.00. Modi, who specializes in the Consumer Defensive sector, has an average return of -3.8% and a 44.82% success rate on his stock recommendations. Additionally, J.P. Morgan's Andrea Faria Teixeira also issued a Buy rating for Colgate-Palmolive today, while Barclays maintained a Hold rating on the stock on May 1.

Colgate(CL.US)

World Investment Advisors Has $2.03 Million Stock Holdings in Colgate-Palmolive Company $CL

Sell in May and Go Away—Starting With These 3 Stocks

Blackhawk Capital Partners LLC Buys Shares of 11,755 Colgate-Palmolive Company $CL

What Colgate-Palmolive (CL)'s Q1 Margin Squeeze And Reaffirmed 2026 Outlook Mean For Shareholders

Sequoia Financial Advisors LLC Boosts Holdings in Colgate-Palmolive Company $CL

The 2 Best Consumer Staples Stocks to Buy and Hold for Decades

Is Wall Street Bullish or Bearish on Colgate-Palmolive Stock?

JPMorgan lifts Colgate price target to $96: Why emerging markets are powering the defensive trade

RBC Capital Sticks to Its Buy Rating for Colgate-Palmolive (CL)